Previous Close | 3.1700 |
Open | 3.1600 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 2.8603 - 3.2996 |
52 Week Range | 0.5000 - 3.8900 |
Volume | |
Avg. Volume | 2,815,319 |
Market Cap | 536.742M |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.9600 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.06 |
Subscribe to Yahoo Finance Plus to view Fair Value for TSHA
Taysha Gene Therapies, Inc. ( NASDAQ:TSHA ) shareholders will have a reason to smile today, with the analysts making...
Taysha Gene Therapies ( NASDAQ:TSHA ) Full Year 2023 Results Key Financial Results Revenue: US$15.5m (up by US$12.9m...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript March 19, 2024 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $0.92, expectations were $-0.09. TSHA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […]